Clearside Biomedical to Present at the 2018 UBS Global Health Care Conference

World News: . []

ALPHARETTA, Ga., May 16, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a late-stage clinical biopharmaceutical company developing first-in-class drug therapies to treat back-of-the-eye diseases, announced today that its Chief Executive Officer and President, Daniel H. White, will present at the 2018 UBS Global Health Care Conference on Tuesday, May 22, 2018 at 3:00 p.m. ET at the Grand Hyatt New York hotel in New York, NY.

A live webcast of the presentation can be accessed on the company’s website at www.clearsidebio.com under the “Events & Presentations” tab in the “Investor Relations” section.  Following the conference, the presentation webcast will be archived on the website for approximately 30 days.

Clearside Biomedical, Inc., headquartered in Alpharetta, GA, is a late-stage clinical ophthalmic biopharmaceutical company that envisions a world without blindness.  Clearside relentlessly pursues transformative, elegant, precise solutions to restore and preserve vision.  Clearside is developing advanced clinical and preclinical product candidates using a proprietary treatment approach offering unprecedented access to the back of the eye through the SCS™.  This has the potential to offer meaningful treatment benefit to patients suffering from sight-threatening diseases like uveitis, retinal vein occlusion, diabetic macular edema and wet age-related macular degeneration.  To learn more about how Clearside is changing ophthalmology, please visit us at .

Stephen KilmerInvestor Relations(678) 270-3631stephen.kilmer@clearsidebio.com

Charles DeignanChief Financial Officer(678) 270-4005charlie.deignan@clearsidebio.com

More news and information about Clearside Biomedical, Inc.

Published By:

Globe Newswire: 21:30 GMT Wednesday 16th May 2018

Published: .

Search for other references to "clearside" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Ground Floor Offices, Little Keep Gate, Barrack Road, Dorchester, Dorset DT1 1AH
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us
 

Advertising on SPi News: Information For Advertisers